Image
29.06.2021
National Paediatric Diabetes Audit identifies widening inequality gap ...
New data from the National Paediatric Diabetes Audit (NPDA) has revealed a six-year trend of widening ine...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more